Cliniques Universitaires Saint-Luc

Woluwe-Saint-Lambert 1200

3 studies enrolling now · 14 studies all time

What they study most

Acute Kidney Injury Due to Sepsis, Avascular Necrosis, Conditional Revision of the Articular Surface, Conditional Tibial Condyle or Plateau Fractures, Cystic Fibrosis, Hematological Malignancies, Hip Fractures, Huntington Disease, Indolent Systemic Mastocytosis, Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell, Multifocal Motor Neuropathy, Myelofibrosis

Studies at this site

• Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
• Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma — Stopped early
• A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy — Running, not enrolling
• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC — Completed
• Persona Partial Knee Clinical Outcomes Study — Running, not enrolling
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 — Completed
• SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors — Running, not enrolling
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI — Stopped early
• Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis — Status unconfirmed
• HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial — Completed